welcome
Investor's Business Daily

Investor's Business Daily

Business

Business & Economics

Boston Sci Slips Despite Cardiovascular-Driven Beat

Investor's Business Daily
Summary
Nutrition label

84% Informative

Boston Scientific ( BSX ) reported adjusted earnings of 70 cents per share on $4.56 billion in fourth-quarter sales.

Sales from its cardiovascular division advanced nearly 29% on a strict, as-reported basis, while medical-surgical sales rose 12.4% . For the year , the medtech giant guided to earnings of $ 2.80 per share and 10% to 12% organic sales growth.

VR Score

89

Informative language

90

Neutral language

51

Article tone

formal

Language

English

Language complexity

25

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Affiliate links

no affiliate links